Abstract
Introduction Hip fractures are an important health problem worldwide, and several factors are associated with the mortality. This study aimed to investigate the factors associated with hip fractures in the elderly, based on studies on the population residing in Brazil, and the relationship of fractures with mortality.
Method Prospective and retrospective primary observational studies including hospitalized men and/or women aged 60 or older presenting hip fracture due to bone fragility were selected on the Databases. Independent researchers conducted the study selection process and data extraction. A meta-analysis was performed to determine the hospital mortality rate at 90 days, six months, and one year. The Newcastle-Ottawa scale (NOS) was used to assess the quality of the included studies, and the meta-analysis followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA).
Result Twenty-five studies totalizing 3,949 patients were included in the systematic review. The population was mainly composed of women (2,680/67.86%). Most patients were in the age group of 70 to 80 years old. Meta-analysis findings: 1) hospital mortality (19 studies, n = 3,175), 10.22% (95% CI 7.27–14.17%; I2 88%); 2) 90-day mortality (3 studies, n = 543), 9.74% (95% CI 3.44–24.62%; I2 90%); 3) six-month mortality (3 studies, n = 205), 24.78% (95% CI 17.07–34.51%; I2 51%); 4) one-year mortality (13 studies, n = 2,790), 21.88% (95% CI 17.5–26.99%; I2 88%). The factors most related to mortality in the studies were: 1) demographic: Older age, male sex; 2) Attributed to clinical conditions: high scoring in preoperative risk scores, comorbidities, neurological/cognitive disorders, functional status; and 3) hospital factors: preoperative period and infections.
Conclusion This review identified variables, including functional status and cognitive changes, related to hip fracture mortality. Knowing these predictors allows for early intervention and planning to adapt health systems to the growing demands of the elderly population.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
MRCGN Grant number: 0006400000044/2019-21 Funder: Fundação de Ensino e Pesquisa em Ciências da Saúde http://www.fepecs.edu.br/ Yes. Concecpetualization, Funding acquisition, Metodology, Project administration, Supervision
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was registered on the International Prospective Register of Systematic Reviews (Prospero) under number CRD42019129953.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Not Applicable
Footnotes
E-mail: ritanovaes2{at}gmail.com
E-mail: paulomedical{at}gmail.com
E-mail: anapmgomides{at}gmail.com
E-mail: j.geber{at}hc.fm.usp.br
E-mail: amandacrissouza1{at}gmail.com
E-mail: amandazzz{at}gmail.com
E-mail: nmdsalbuquerque{at}gmail.com
E-mail: J.milhomemmosquera{at}sempreceub.com
E-mail: henrymaiap9{at}gmail.com
FUNDING MRCGN
Grant number: 0006400000044/2019-21
Funder: Fundação de Ensino e Pesquisa em Ciências da Saúde http://www.fepecs.edu.br/
Viviane Cristina Uliana Peterle, MD, MsC, PhD Conceptualization; Data curation; Formal Analysis; Funding Acquisition; Investigation; Methodology; Project Administration; Resources; Software; Validation; Visualization; Writing – Original Draft Preparation; Writing – Review & Editing.
Maria Rita Carvalho Garbi Novaes, PhD Conceptualization; Data curation; Formal Analysis; Funding Acquisition; Investigation; Methodology; Project Administration; Resources; Software; Validation; Visualization; Writing – Original Draft Preparation; Writing – Review & Editing.
Paulo Emiliano Bezerra Junior, MD, MsC 1,6,7,11 Conceptualization; Methodology; Project; Administration; Visualization
Ana Paula Monteiro Gomides Reis, MD, MsC, PhD 5,6,8,12 Investigation; Methodology; Resources; Writing – Review & Editing.
João Carlos Geber Júnior, MD 2,3,9 Data curation; Formal Analysis; Software.
Amanda Cristina de Souza, MD 2,3,5, 8 Data curation; Formal Analysis; Investigation; Resources.
Amanda Ribeiro Alves, MD 2,3,5, 8 Data curation; Formal Analysis; Investigation; Resources.
Natalia Mariana Diogenes Silva de Albuquerque, MD 2,3,5, 8 Data curation; Formal Analysis; Investigation; Resources.
Júlia Milhomem Mosquéra, MD 2,3,5, 8 Data curation; Formal Analysis; Investigation; Resources.
Henry Maia Peixoto, MsC, PhD 1-13 Conceptualization; Data curation; Formal Analysis; Funding Acquisition; Investigation; Methodology; Project Administration; Resources; Software; Validation; Visualization; Writing – Original Draft Preparation; Writing – Review & Editing.
Data Availability
All relevant data are within the manuscript and its Supporting Information files.